Press release
Alzheimers Disease Biomarkers Market Projected to Surpass a Valuation of USD 1.7 Billion by 2031
Alzheimers Disease Biomarkers Market
Get Exclusive PDF Sample Copy of Alzheimer's Disease Biomarkers Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=44970&utm_source=OpenPR_Ajay&utm_medium=OpenPR
The prevalence of Alzheimer's disease, often affecting older individuals, is on the rise due to factors such as an aging population and lifestyle-related risks. As a result, there is a growing demand for Alzheimer's disease biomarker testing, which is anticipated to drive market growth in the coming years.
According to data from the Harvard Chan School (2020) and Alzheimer's Society (2022), the global population suffering from dementia is expected to triple over the next 30 years. The risk of developing dementia increases with age, with individuals over the age of 90 being particularly susceptible. Lifestyle factors such as alcohol consumption, physical activity, diet, sleep patterns, social engagement, and mental stimulation also play significant roles in the development of Alzheimer's disease and cognitive decline.
Key findings from the research highlight the importance of cerebrospinal fluid (CSF) biomarkers in predicting disease progression and aiding in clinical decision-making. The immunoassay technique is gaining popularity due to its cost-effectiveness and simplicity, contributing to its anticipated prominent share in the Alzheimer's disease biomarkers market.
Factors driving market growth include the increasing older population, rising prevalence of neurological diseases, and sedentary lifestyles. Regionally, North America is expected to experience notable growth, fueled by the high prevalence of neurological diseases, robust research and development activities, and the presence of key market players. Similarly, Asia Pacific is expected to witness growth due to the rising prevalence of dementia, Parkinson's disease, and Alzheimer's disease.
Key players profiled in the report include Thermo Fisher Scientific, Inc., Enzo Life Sciences, Inc., Merck KGaA, AnaSpec, Inc., Fujirebio, Cell Signaling Technology, Inc., NanoSomiX, Imagilys, 23andMe, Inc., QIAGEN, C₂N Diagnostics, Quanterix, and Quest Diagnostics.
The market segmentation includes various types of biomarkers such as CSF biomarkers, genetic biomarkers, and blood biomarkers, along with different detection techniques and end-users. The regions covered in the report include North America, Europe, Asia Pacific, and the Rest of the World.
Ask for References - https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=44970&utm_source=OpenPR_Ajay&utm_medium=OpenPR
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Alzheimers Disease Biomarkers Market Projected to Surpass a Valuation of USD 1.7 Billion by 2031 here
News-ID: 3374441 • Views: …
More Releases from Transparency Market Research
Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 …
The global solar powered agricultural dryer market, valued at US$ 1.6 billion in 2022, is projected to grow at a CAGR of 5.8% from 2023 to 2031, reaching US$ 2.4 billion by the end of 2031. Rising investments in renewable energy, growing awareness of sustainable agricultural practices, and the rapid expansion of the agricultural sector driven by population growth are key factors fueling market growth.
Uncover essential discoveries and trends from…
Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Ra …
The global Technetium‐99m Market was valued at US$ 6.0 Billion in 2023 and is projected to grow at a CAGR of 3.3% from 2024 to 2034, surpassing US$ 8.6 Billion by the end of the forecast period. Advancements in nuclear imaging infrastructure, government-backed healthcare initiatives, and an increasing demand for precise diagnostic procedures are fueling this growth.
Discover essential conclusions and data from our Report in this sample -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77100
Analysts' Viewpoint
The Technetium‐99m…
Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to …
The global Equine Diagnostic Services Market, valued at approximately US$ 168 million in 2019, is projected to expand at a compound annual growth rate (CAGR) of ~5% from 2020 to 2030, reaching around US$ 280 million by 2030. Equine diagnostic services, encompassing tests like genetic, infectious disease, and imaging diagnostics, are critical for managing horse health in veterinary hospitals, clinics, and mobile settings. The market is driven by increasing equine…
Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of …
The digital printing market is experiencing strong growth, driven by rapid technological advancements, rising demand for personalized and on-demand printing, and an increasing focus on sustainable solutions. Digital printing allows for the direct transfer of digital files onto a wide range of substrates, offering high-resolution output with greater speed and flexibility. Its adaptability has led to broad adoption across industries such as packaging, textiles, publishing, and advertising-sectors where customization, efficiency,…
More Releases for Alzheimer
Dementia - Alzheimer Disease Market: A Comprehensive Analysis 2030
Dementia and Alzheimer's disease represent significant challenges within the global healthcare sector. These neurological disorders, characterized by progressive cognitive decline, have seen increasing prevalence due to aging populations worldwide. This growing burden has spurred interest in the Dementia - Alzheimer's disease market, encompassing diagnostic tools, treatments, caregiving solutions, and related healthcare services. This article provides an overview of the market, its scope, current trends, and factors driving its expansion.
Data Bridge…
Alzheimer Disease Treatment Market | Allergan, Amgen, Daiichi Sankyo, Eisai
The global alzheimer disease treatment market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the alzheimer disease treatment market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
United States Alzheimer Drugs Market Insights Deep Analysis 2023-2031
Cognate Life Sciences introduces a report on "United States Alzheimer Drugs Market 2023" with Market Insights Reports, Introduces systematic details in terms of market valuation, market size, revenue estimation, and geographical spectrum of the business vertical. The study also talks about crucial pockets of the industry such as products or services offered, downstream fields, end using customers, historic data figures regarding revenue and sales, market context and more. It conjointly…
Global Alzheimer Market, Global Alzheimer Industry, Covid-19 Impact Global Alzhe …
Alzheimer's is a progressive disease that leads to the death of brain cells, resulting in memory loss, behavioral issues, and disruption the thought processes. The Alzheimer disease is considered fatal. Age and heredity are the two main risk factors for developing Alzheimer's disease. Several other preventable risk factors have been associated to the development of this disease, including diet, environment, and overall general health. A combination of risk factors is…
US Alzheimer Drug Pipeline Analysis
In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimer’s disease was 5.4 million in 2012. Out of this,…
Global Alzheimer Market Report: 2015 Edition | Now Available at Researchmoz.us
Researchmoz added Most up-to-date research on "Global Alzheimer Market Report: 2015 Edition" to its huge collection of research reports.
Alzheimer’s disease is defined as an advanced neurological disorder that increasingly deprives patients of their memory and ability to carry out daily activities. As it grows in a human brain, individuals are likely to practice difficulties in linguistic, agility and insight along with negative changes in the character and performance such as…
